This PhD student blog post explores the use of machine learning for simultaneously optimizing antibody affinity and specificity, which could help accelerate drug development.
Biomolecular Engineering
Behind the Paper: Enabling Multi-Objective Antibody Optimization
$2.38M to test nano-engineered brain cancer treatment in mice
A protein that crosses the blood-brain barrier carries a drug that kills tumor cells and another that activates the immune system.
Joerg Lahann receives funding to improve cancer-fighting technologies
U-M ChE’s Joerg Lahann, the Wolfgang Pauli Collegiate Professor of Chemical Engineering, has received funding for a joint industry-academic cancer research project with Gradalis. The research focuses on finding methods to utilize a patient’s cancer cells to create personalized therapeutics to treat cancer.
Sasha Cai Lesher-Pérez to join U-M Chemical Engineering in 2022
Sasha Cai Lesher-Pérez will join U-M Chemical Engineering in Fall 2022 as an assistant professor.
New protein engineering method could accelerate the discovery of COVID-19 therapeutics
The method could one day be used to develop nanobodies against other viruses and disease targets as well.
